tradingkey.logo
tradingkey.logo
검색

Boston Scientific Corp

BSX
관심 목록에 추가
44.205USD
-0.255-0.57%
종가 06/25, 16:00ET시세는 15분 지연됩니다
65.70B시가총액
18.39P/E TTM

Boston Scientific Corp

44.205
-0.255-0.57%

자세한 내용은 Boston Scientific Corp 회사

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Boston Scientific Corp 정보

종목 코드 BSX
회사 이름Boston Scientific Corp
상장일May 19, 1992
CEOMahoney (Michael F)
직원 수53000
유형Ordinary Share
회계 연도 종료May 19
주소300 Boston Scientific Way
도시MARLBOROUGH
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호01752-1234
전화15086834000
웹사이트https://www.bostonscientific.com/en-US/Home.html
종목 코드 BSX
상장일May 19, 1992
CEOMahoney (Michael F)

Boston Scientific Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
13.88K
+59.45%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%

자주 묻는 질문

Boston Scientific Corp의 상위 5대 주주는 누구인가요?

Boston Scientific Corp의 상위 5대 주주는 다음과 같습니다: Mr. Michael F. (Mike) Mahoney

Boston Scientific Corp(BSX)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Boston Scientific Corp의 주식을 보유한 기관은 총 3113곳이며, 이들이 보유한 주식의 총 가치는 약 1.40B로 전체 발행 주식의 94.35%를 차지합니다. 이는 2025Q4 대비 -15512534.00 증가한 수치입니다.

Boston Scientific Corp의 최대 수익원은 무엇인가요?

2026Q1 기준, Boston Scientific Corp의 Interventional Cardiology Therapies 부문이 가장 높은 매출을 기록했으며, 금액은 4.64B로 전체 매출의 23.11%를 차지했습니다.
KeyAI